Study of serum and urine hydroxyproline level of patients with prostatic cancer

I. Romics, L. Lengyel

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The serum and urine hydroxyproline levels of patients with prostatic cancer were regularly studied for 30 months. Bone metastases were found in 4 patients at the beginning of the study; metastases formed in 8 patients during the test period, and in 9 patients no metastases formed during the study. At the time of X-ray diagnosis of metastasis, significantly higher serum and urine hydroxyproline levels and enzymatic phosphatase were found, but in the tests performed 3 months earlier, in spite of the negative X-ray results, the hydroxyproline results differed significantly from the reference values. The above findings support the use of the hydroxyproline test for the diagnosis of metastases.

Original languageEnglish
Pages (from-to)395-397
Number of pages3
JournalEuropean Urology
Volume10
Issue number6
Publication statusPublished - 1984

Fingerprint

Hydroxyproline
Prostatic Neoplasms
Urine
Neoplasm Metastasis
Serum
X-Rays
Phosphoric Monoester Hydrolases
Reference Values
Bone and Bones

ASJC Scopus subject areas

  • Urology

Cite this

Study of serum and urine hydroxyproline level of patients with prostatic cancer. / Romics, I.; Lengyel, L.

In: European Urology, Vol. 10, No. 6, 1984, p. 395-397.

Research output: Contribution to journalArticle

@article{21337a656d0145a8bd22945cf4141e7b,
title = "Study of serum and urine hydroxyproline level of patients with prostatic cancer",
abstract = "The serum and urine hydroxyproline levels of patients with prostatic cancer were regularly studied for 30 months. Bone metastases were found in 4 patients at the beginning of the study; metastases formed in 8 patients during the test period, and in 9 patients no metastases formed during the study. At the time of X-ray diagnosis of metastasis, significantly higher serum and urine hydroxyproline levels and enzymatic phosphatase were found, but in the tests performed 3 months earlier, in spite of the negative X-ray results, the hydroxyproline results differed significantly from the reference values. The above findings support the use of the hydroxyproline test for the diagnosis of metastases.",
author = "I. Romics and L. Lengyel",
year = "1984",
language = "English",
volume = "10",
pages = "395--397",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - Study of serum and urine hydroxyproline level of patients with prostatic cancer

AU - Romics, I.

AU - Lengyel, L.

PY - 1984

Y1 - 1984

N2 - The serum and urine hydroxyproline levels of patients with prostatic cancer were regularly studied for 30 months. Bone metastases were found in 4 patients at the beginning of the study; metastases formed in 8 patients during the test period, and in 9 patients no metastases formed during the study. At the time of X-ray diagnosis of metastasis, significantly higher serum and urine hydroxyproline levels and enzymatic phosphatase were found, but in the tests performed 3 months earlier, in spite of the negative X-ray results, the hydroxyproline results differed significantly from the reference values. The above findings support the use of the hydroxyproline test for the diagnosis of metastases.

AB - The serum and urine hydroxyproline levels of patients with prostatic cancer were regularly studied for 30 months. Bone metastases were found in 4 patients at the beginning of the study; metastases formed in 8 patients during the test period, and in 9 patients no metastases formed during the study. At the time of X-ray diagnosis of metastasis, significantly higher serum and urine hydroxyproline levels and enzymatic phosphatase were found, but in the tests performed 3 months earlier, in spite of the negative X-ray results, the hydroxyproline results differed significantly from the reference values. The above findings support the use of the hydroxyproline test for the diagnosis of metastases.

UR - http://www.scopus.com/inward/record.url?scp=0021709550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021709550&partnerID=8YFLogxK

M3 - Article

C2 - 6529955

AN - SCOPUS:0021709550

VL - 10

SP - 395

EP - 397

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 6

ER -